e-learning
resources
Virtual 2021
05.09.2021
Chronic COVID - 19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of persistent D-Dimer elevation following recovery from COVID-19
A. Lehmann (Vienna, Austria), H. Prosch (Vienna, Austria), S. Zehetmayer (Vienna, Austria), M. Gysan (Vienna, Austria), M. Idzko (Vienna, Austria), D. Gompelmann (Vienna, Austria)
Source:
Virtual Congress 2021 – Chronic COVID - 19
Session:
Chronic COVID - 19
Session type:
Oral Presentation
Number:
90
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lehmann (Vienna, Austria), H. Prosch (Vienna, Austria), S. Zehetmayer (Vienna, Austria), M. Gysan (Vienna, Austria), M. Idzko (Vienna, Austria), D. Gompelmann (Vienna, Austria). Impact of persistent D-Dimer elevation following recovery from COVID-19. 90
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients
Source: Eur Respir J, 56 (4) 2001811; 10.1183/13993003.01811-2020
Year: 2020
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Exercise induced elevation of high-sensitive troponin T serum levels in patients with pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004
Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009
Raised d-dimer levels in acute sickle cell crisis and their correlation with chest x-ray abnormalities
Source: Eur Respir J 2005; 26: Suppl. 49, 522s
Year: 2005
Elevated plasma EPCR levels early post ICU admission predict sepsis development
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Prognostic value of D-dimer, BNP and CRP in acute pulmonary thromboembolism and relationship with echocardiography
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration
Source: Eur Respir J 2006; 28: Suppl. 50, 402s
Year: 2006
The role of D-dimers with immuno-turbidimetric assay in the initial management of pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia?
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Does D-dimer levels on admission predicts venous thromboembolism in patients with COVID-19?
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021
Relationship between severity of disease and D-dimer levels which were measured with two different methods in pulmonary embolism patients
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
Association between C-reactive protein levels and outcome in acute lung injury in children
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Measurement of Gas6 protein in patients with acute dyspnea
Source: Eur Respir J 2007; 30: Suppl. 51, 51s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept